Last quarter (Q4 2024), Sonnet BioTherapeutics Holdings's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Sonnet BioTherapeutics Holdings's net income was $-3.13M. See Sonnet BioTherapeutics Holdings’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Sep 24	Sep 23	Sep 22	Sep 21	Sep 20
Total Revenue	$ 18.63K	$ 18.63K	$ 100.00K	$ 349.94K	$ 483.63K	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ 18.63K	$ 18.63K	$ 100.00K	$ 300.00K	$ 483.63K	$ ―
Operating Expense	$ 11.87M	$ 11.87M	$ 18.94M	$ 30.02M	$ 25.57M	$ 24.24M
Operating Income	$ -11.85M	$ -11.85M	$ -18.79M	$ -29.67M	$ -25.09M	$ -24.24M
Net Non Operating Interest Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ 20.68K
Other Income Expense	$ -4.30M	$ -4.30M	$ -40.08K	$ -52.48K	$ -125.50K	$ ―
Pretax Income	$ 299.89K	$ -7.47M	$ -18.88M	$ -29.72M	$ -24.98M	$ -24.27M
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -7.44M	$ -7.44M	$ -18.88M	$ -29.72M	$ -24.98M	$ -65.60M
Basic EPS	$ -4.26	$ -11.35	$ -18.14	$ -150.48	$ -314.16	$ -2.14K
Diluted EPS	$ -4.27	$ -11.35	$ -18.14	$ -150.48	$ -314.16	$ -2.14K
Basic Average Shares	$ 14.39M	$ 655.24K	$ 1.04M	$ 197.64K	$ 79.70K	$ 30.59K
Diluted Average Shares	$ 14.63M	$ 655.24K	$ 1.04M	$ 197.64K	$ 79.70K	$ 30.59K
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 11.87M	$ 11.87M	$ 18.94M	$ 30.02M	$ 25.57M	$ 24.24M
Net Income From Continuing And Discontinued Operation	$ -7.44M	$ -7.44M	$ -18.83M	$ -29.72M	$ -24.98M	$ -24.27M
Normalized Income	$ -15.41M	$ -7.39M	$ -14.92M	$ ―	$ -19.74M	$ ―
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -7.55M	$ -7.44M	$ -18.88M	$ -29.67M	$ -25.09M	$ -17.41M
EBITDA	$ -7.46M	$ -7.35M	$ -18.80M	$ -29.58M	$ -24.99M	$ -17.35M

Currency in USD

Sonnet BioTherapeutics Holdings Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing